|
|
|
|
Diffuse large B cell lymphoma
|
| |
|
| |
Diffuse large B-cell lymphoma (DLBL or DLBCL) is a type of aggressive lymphoma. It accounts for approximately 40% of lymphomas among adults. Of all cancers involving the same class of blood cell, 31% of cases are DLBL.

Discussion
Ask a question about 'Diffuse large B cell lymphoma'
Start a new discussion about 'Diffuse large B cell lymphoma'
Answer questions from other users
|
Encyclopedia
Diffuse large B-cell lymphoma (DLBL or DLBCL) is a type of aggressive lymphoma. It accounts for approximately 40% of lymphomas among adults. Of all cancers involving the same class of blood cell, 31% of cases are DLBL.
Classification
Two or three major subtypes of DLBL have been identified based on their genetic activity:
- activated (ABC-DLBCL), with a pattern of genetic expression that is similar to healthy, activated B cells, and
- germinal center (GCB-DLBCL), with a pattern of genetic expression that is similar to germinal center B cells and a chromosomal translocation involving the gene bcl-2. This type has a relatively favorable prognosis.
- primary mediastinal B-cell lymphoma (PMBL)
Chromosome anomalies are:
- t(14;18)(q32;q21) with BCL2-rearrangement.
- t(3;Var)(q27;Var) with BCL6-rearrangement. These are common translocations.
- t(8;14)(q24;q32) with MYC rearrangements.
- and other less characteristic anomalies.
Treatment
Standard treatment is CHOP. An expanded protocol, called CHOP-R, has improved survival and rates of complete responses for DLBL patients, particularly elderly patients.
Prognosis
The germinal center subtype has the best prognosis, with 60% of treated patients surviving more than five years.
|
| |
|
|